Lloyds Banking Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,910
| Closed | -$144K | – | 70 |
|
|
2018
Q1 | $144K | Buy |
1,910
+105
| +6% | +$7.92K | 1.11% | 38 |
|
|
2017
Q4 | $129K | Hold |
1,805
| – | – | 1.2% | 38 |
|
|
2017
Q3 | $146K | Sell |
1,805
-161
| -8% | -$13K | 1.46% | 29 |
|
|
2017
Q2 | $139K | Sell |
1,966
-41
| -2% | -$2.9K | 1.35% | 35 |
|
|
2017
Q1 | $136K | Sell |
2,007
-210
| -9% | -$14.2K | 1.23% | 39 |
|
|
2016
Q4 | $158K | Sell |
2,217
-96
| -4% | -$6.84K | 1.37% | 36 |
|
|
2016
Q3 | $183K | Sell |
2,313
-67
| -3% | -$5.3K | 1.64% | 34 |
|
|
2016
Q2 | $198K | Hold |
2,380
| – | – | 1.63% | 33 |
|
|
2016
Q1 | $218K | Buy |
+2,380
| New | +$218K | 1.78% | 27 |
|
|
2014
Q4 | – | Sell |
-25,626
| Closed | -$2.73M | – | 196 |
|
|
2014
Q3 | $2.73M | Buy |
25,626
+3,940
| +18% | +$419K | 0.74% | 27 |
|
|
2014
Q2 | $1.8M | Sell |
21,686
-1,064,968
| -98% | -$88.2M | 0.43% | 65 |
|
|
2014
Q1 | $77M | Buy |
1,086,654
+231,579
| +27% | +$16.4M | 0.69% | 34 |
|
|
2013
Q4 | $64.3M | Buy |
855,075
+59,077
| +7% | +$4.44M | 0.58% | 49 |
|
|
2013
Q3 | $50M | Buy |
795,998
+200,475
| +34% | +$12.6M | 0.51% | 56 |
|
|
2013
Q2 | $30.5M | Buy |
+595,523
| New | +$30.5M | 0.32% | 82 |
|